Healthcare -
Biotechnology - NASDAQ - US
$ 6.295
-0.71 %
$ 430 M
Market Cap
-1.1
P/E
PHAT - ACCOUNTS PAYABLE
Accounts Payable PHAT - Phathom Pharmaceuticals, Inc.
12.6 M
LAST VALUE
56.42%
2 YEAR CAGR
196.49%
5 YEAR CAGR
0.00%
10 YEAR CAGR